MicroRNA-based therapy: a new dimension in epilepsy treatment.

scientific article published on 09 May 2013

MicroRNA-based therapy: a new dimension in epilepsy treatment. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/00207454.2013.789513
P8608Fatcat IDrelease_fgl2mj2yobc4jc63yix3vbbike
P698PubMed publication ID23528011

P50authorMridul RoyQ85240335
P2093author name stringHao Liu
Fa-Fa Tian
P2860cites workThe nuclear RNase III Drosha initiates microRNA processingQ24295234
Ribonuclease activity and RNA binding of recombinant human DicerQ24315047
MicroRNA genes are transcribed by RNA polymerase IIQ24562649
Asymmetry in the assembly of the RNAi enzyme complexQ27860763
Oncomirs - microRNAs with a role in cancerQ27860773
Functional siRNAs and miRNAs Exhibit Strand BiasQ27861038
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
Epilepsy: contemporary perspectives on evaluation and treatmentQ28241339
Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)Q28243974
Identification of hundreds of conserved and nonconserved human microRNAsQ28257480
Surgery for seizuresQ28275323
Adenosine A1 and A3 receptors protect astrocytes from hypoxic damageQ28291855
Adult epilepsyQ28304952
The evolution of gene regulation by transcription factors and microRNAsQ29617552
Repression of protein synthesis by miRNAs: how many mechanisms?Q29620361
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effectsQ30524857
Inhibitory RNA in epilepsy: research tools and therapeutic perspectivesQ34126428
Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/bQ34168627
Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures.Q34170732
A prospective study of the requirement for and the provision of epilepsy surgery in the United KingdomQ34197701
Socioeconomic variation in incidence of epilepsy: prospective community based study in south east EnglandQ34204865
Life expectancy in people with newly diagnosed epilepsyQ34348765
MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus.Q34418730
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory responseQ34427432
Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizuresQ34992471
Clinically important change in quality of life in epilepsy.Q35468261
miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132Q35475193
Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulationQ35606143
The use of antiepileptic drugs--principles and practiceQ35865176
Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosisQ35962195
Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune responseQ36192088
Gene expression profile in temporal lobe epilepsyQ36778564
Adenosine as a neuromodulator in neurological diseasesQ36974004
Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cellsQ37426965
Intracellular toll-like receptorsQ37719951
Epileptic seizures and spirit possession in Haitian culture: Report of four cases and review of the literatureQ37781202
The role of inflammation in epileptogenesisQ38004250
Insights into inflammation and epilepsy from the basic and clinical sciencesQ38019256
Neurotrophin-3 mRNA a putative target of miR21 following status epilepticusQ38330929
Possible role of the innate immunity in temporal lobe epilepsy.Q38514811
Engineering human mesenchymal stem cells to release adenosine using miRNA technologyQ39670945
Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsyQ39893640
Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus.Q42252596
MicroRNA-34a upregulation during seizure-induced neuronal deathQ42560262
Quality of life of people with epilepsy: a European studyQ43524508
Epilepsy in the developing world.Q45974518
Adenosine kinase and ribokinase--the RK family of proteinsQ46534681
The epidemiology of epilepsy: the size of the problemQ47205746
Complement activation in experimental and human temporal lobe epilepsyQ48215408
Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme.Q48465634
Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsyQ48469394
Prolonged increase in rat hippocampal chemokine signalling after status epilepticusQ48649560
Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus.Q54396512
EpilepsyQ55899118
Mortality in epilepsyQ56047944
Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrenceQ57808296
Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohortQ58449920
P433issue9
P304page(s)617-622
P577publication date2013-05-09
P1433published inInternational Journal of NeuroscienceQ6051511
P1476titleMicroRNA-based therapy: a new dimension in epilepsy treatment
P478volume123

Reverse relations

cites work (P2860)
Q95933559Inhibition of miR-181a-5p reduces astrocyte and microglia activation and oxidative stress by activating SIRT1 in immature rats with epilepsy
Q42040042Synthesis of a FTO inhibitor with anticonvulsant activity.

Search more.